ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,431.60
      -0.04%
      US Tech 100
      19,166.40
      0.51%
      Dow Jones
      38,589.16
      -0.15%
      Brent Oil
      82.275
      0.00%
      Bitcoin
      66,131.46
      0.19%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aprea Therapeutics Inc (APRE)

      7. Aprea Therapeutics Inc (APRE) News

      APRE

      Aprea Therapeutics (APRE)

      Aprea Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:APRE
      DateTimeSourceHeadlineSymbolCompany
      6:07AMiHub NewswireFeaturedFifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates
      05/14/20248:40AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
      05/14/20248:35AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APREAprea Therapeutics Inc
      02/06/20245:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
      02/05/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:APREAprea Therapeutics Inc
      02/02/20244:26PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
      01/26/20247:13AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
      01/26/20246:03AMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:APREAprea Therapeutics Inc
      01/04/20244:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
      11/09/20234:20PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:APREAprea Therapeutics Inc
      11/09/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
      11/09/20234:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APREAprea Therapeutics Inc
      10/16/20235:29PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
      10/13/20237:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
      09/11/20238:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
      08/24/20239:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APREAprea Therapeutics Inc
      08/24/20239:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APREAprea Therapeutics Inc
      08/24/20239:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APREAprea Therapeutics Inc
      08/24/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
      08/10/20237:39AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APREAprea Therapeutics Inc
      08/10/20237:36AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
      07/11/20237:40AMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:APREAprea Therapeutics Inc
      07/11/20237:30AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:APREAprea Therapeutics Inc
      07/05/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
      06/14/20238:00AMGlobeNewswire Inc.Aprea Therapeutics to Present at Maxim Virtual Healthcare ConferenceNASDAQ:APREAprea Therapeutics Inc
      06/08/20234:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APREAprea Therapeutics Inc
      05/30/20238:30AMGlobeNewswire Inc.Aprea Therapeutics to Present at BIO International ConventionNASDAQ:APREAprea Therapeutics Inc
      05/15/20234:48PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APREAprea Therapeutics Inc
      05/15/20234:40PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APREAprea Therapeutics Inc
      05/15/20234:05PMGlobeNewswire Inc.Aprea Therapeutics Reports First Quarter 2023 Financial Results and Provides Update on Business OperationsNASDAQ:APREAprea Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:APRE